Skip to main content
Menu
US

GSP Neonatal Creatine Kinase -MM kit

The GSP Neonatal Creatine Kinase –MM kit is a solid phase, two-site fluoroimmunometric assay based on the direct sandwich technique. Analyte is bound to monoclonal CK-MM specific antibodies. The fluorescence signal is proportional to the analyte concentration in the sample.

Products may not be licensed in accordance with the laws in all countries, such as the United States and Canada. Please check with your local representative for availability.

Overview

This assay measures muscle specific creatine kinase in dried blood spots, helping to detect newborns affected by Duchenne Muscular Dystrophy.

Revvity's GSP® Neonatal Creatine Kinase –MM kit is an immunoassay for measuring CK-MM in dried blood spot samples of newborn babies. As the assay measures the muscle specific isoform, it enables the screening process to find the babies affected by DMD. The kit is available on Revvity's GSP® instrument, a fully automated, high throughput biochemical analyzer.

Benefits of the assay:

  • The first CE-IVD kit for Duchenne Muscular Dystrophy screening
  • Fully automated – no reagent preparation
  • High sensitivity and specificity – good separation between affected and unaffected cases
  • Wide measuring range enabling numerical result also from most of the non-affected cases
  • Kit includes reagents, QC material and specific QC certificates
  • Robust and reliable DELFIA® platform performance

Specifications

Application
Newborn Screening
Assay Points
500
Automation Compatible
Yes
Brand
GSP®
Detection Method
Enzymatic
Disorders
Duchenne Muscular Dystrophy
Format
Microplates
SDS, COAs, Manuals and more Illuminator

SDS, COAs, Manuals and more

Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.

Scroll Icon